Kestra Medical
KMTS
Kestra Medical (KMTS) earnings history
Most recent quarter
- Fiscal period
- Q4 2026
- Period end
- Apr 30, 2026
- EPS actual
- −$0.67
- EPS estimate
- −$0.59
- EPS surprise
- −13.56%
- Revenue surprise
- +8.15%
- Revenue
- $28.6M
- Revenue estimate
- $26.5M
- Reported
- Jul 14, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2026 | Jul 14, 2026 | −$0.59 | −$0.67 | −13.56% | $28.6M | SEC |
| Q3 2026 | Mar 17, 2026 | −$0.60 | −$0.61 | −2.33% | $24.6M | SEC |
| Q2 2026 | Dec 11, 2025 | −$0.59 | −$0.64 | −7.73% | $22.6M | SEC |
| Q1 2026 | Sep 11, 2025 | −$0.61 | −$0.50 | +18.03% | $19.4M | SEC |
| Q4 2025 | Jul 15, 2025 | −$0.53 | −$2.21 | −320.95% | $17.2M | SEC |
| Q3 2025 | Apr 14, 2025 | −$0.60 | −$1.25 | −107.19% | $15.1M | SEC |
Quarterly revenue
Frequently asked questions
When did Kestra Medical (KMTS) last report earnings?
Kestra Medical last reported on Jul 14, 2026, covering fiscal Q4 2026.
Did KMTS beat earnings estimates?
No. Kestra Medical reported EPS of −$0.67 for Q4 2026 against a −$0.59 estimate — a 13.56% miss.
How much revenue did KMTS report last quarter?
Kestra Medical reported $28.6M in revenue for Q4 2026, against a consensus estimate of $26.5M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.